These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11412282)

  • 1. Influence of a combination of herbs on appetite suppression and weight loss in rats.
    Talpur NA; Echard BW; Manohar V; Preuss HG
    Diabetes Obes Metab; 2001 Jun; 3(3):181-5. PubMed ID: 11412282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical studies with phenylpropanolamine: a metaanalysis.
    Greenway FL
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):203S-205S. PubMed ID: 1530830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic phenylpropanolamine infusion and termination on body weight, food consumption and water consumption in rats.
    Winders SE; Amos JC; Wilson MR; Rushing PA; Dykstra T; Coday MC
    Psychopharmacology (Berl); 1994 Apr; 114(3):513-9. PubMed ID: 7855211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of the appetite suppressant, diethylpropion, is dependent on both when it is given (day vs. night) and under conditions of high fat dietary restriction.
    Kalyanasundar B; Solorio J; Perez CI; Hoyo-Vadillo C; Simon SA; Gutierrez R
    Appetite; 2016 May; 100():152-61. PubMed ID: 26867698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.
    Greenway F; Herber D; Raum W; Herber D; Morales S
    Obes Res; 1999 Jul; 7(4):370-8. PubMed ID: 10440593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss induced by chronic phenylpropanolamine: anorexia and brown adipose tissue thermogenesis.
    Wellman PJ; Sellers TL
    Pharmacol Biochem Behav; 1986 Mar; 24(3):605-11. PubMed ID: 3703896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcript of protein kinase A knock-down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    Physiol Genomics; 2007 Oct; 31(2):306-14. PubMed ID: 17684035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y Y1 receptor knockdown can modify glutathione peroxidase and c-AMP response element-binding protein in phenylpropanolamine-treated rats.
    Hsieh YS; Chen PN; Kuo MH; Kuo DY
    Arch Toxicol; 2013 Mar; 87(3):469-79. PubMed ID: 23052195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the anorectic drug, phenylpropanolamine, on blood glucose in rats.
    Resnick SI; Hernandez L; Chen J; Hoebel BG
    Pharmacology; 1978; 17(3):157-62. PubMed ID: 704658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute administration of phenylpropanolamine fails to affect resting energy expenditure in men of normal weight.
    Rushing PA; Winders SE; Watson SL; Klesges RC
    Obes Res; 1997 Sep; 5(5):470-3. PubMed ID: 9385624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of protein kinase Calpha isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression.
    Kuo DY; Yang SF; Chu SC; Chen CH; Hsieh YS
    J Neurochem; 2009 Mar; 108(6):1495-506. PubMed ID: 19183253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylpropanolamine decreases food intake in rats made hyperphagic by various stimuli.
    Moya-Huff FA; Maher TJ
    Pharmacol Biochem Behav; 1987 Sep; 28(1):71-4. PubMed ID: 3310024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the alpha 1a-adrenoceptor antagonist RS-17053 on phenylpropanolamine-induced anorexia in rats.
    Wellman PJ; McMahon LR; Green T; Tole A
    Pharmacol Biochem Behav; 1997; 57(1-2):281-4. PubMed ID: 9164583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of phenylpropanolamine to reduce nicotine cessation induced weight gain in rats.
    Winders SE; Dykstra T; Coday MC; Amos JC; Wilson MR; Wilkins DR
    Psychopharmacology (Berl); 1992; 108(4):501-6. PubMed ID: 1410166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the effects of phenylpropanolamine on appetite and food intake.
    Caffry EW; Kissileff HR; Thornton JC
    Pharmacol Biochem Behav; 1987 Feb; 26(2):321-5. PubMed ID: 3575355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Behav Neurosci; 2007 Oct; 121(5):933-40. PubMed ID: 17907825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting neuropeptide Y Y1 receptor modulates melanocortin receptor- and NF-κB-mediated feeding behavior in phenylpropanolamine-treated rats.
    Hsieh YS; Chen PN; Yu CH; Liao JM; Kuo DY
    Horm Behav; 2013 Jun; 64(1):95-102. PubMed ID: 23707533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of tolerance to drugs that suppress food intake.
    Fernstrom JD; Choi S
    Pharmacol Ther; 2008 Jan; 117(1):105-22. PubMed ID: 17950459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine.
    Hsieh YS; Yang SF; Chu SC; Kuo DY
    J Neurochem; 2008 Jan; 104(1):50-61. PubMed ID: 17868324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isobolographic assessment of the effects of combinations of phenylpropanolamine and fenfluramine on food intake in rats.
    Wellman PJ; Tow S; McMahon L
    Pharmacol Biochem Behav; 1995 Feb; 50(2):287-91. PubMed ID: 7740069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.